Efficacy and Safety of Citric Acid and Heparin Anticoagulation in Patients with Septic Acute Kidney Injury Undergoing Continuous Renal Replacement Therapy: A Meta-Analysis.

Abstract

Objective:

This meta-analysis compares the clinical efficacy and safety of citrate anticoagulation with heparin anticoagulation in continuous renal replacement therapy for acute kidney injury in sepsis.

Methods:

The experimental group underwent local anticoagulation with citrate, whereas the control group received systemic anticoagulation with heparin. Relevant data from randomized controlled trials (RCTs) meeting the inclusion criteria were independently extracted through computer searches of the China Journal Full Text Database (CNKI), Wanfang, and Vipul databases. Additionally, references to included literature were searched to expand the dataset. Extracted RCTs that met inclusion criteria underwent independent quality evaluation and cross-checking using the Cochrane systematic review method. Subsequently, a meta-analysis was conducted using Stata 12.0 software.

Results:

The analysis included seven studies involving a total of 652 patients. After treatment, renal function improvement was significantly more significant in the citrate group, while creatinine and urea nitrogen levels showed a more significant decrease in the heparin group, with statistically significant differences (WMD = -51.30, 95% CI = -68.54 ~ -34.06, P = .000 and WMD = 3.68, 95% CI = -4.52 ~ -2.85, P = .000). The filter lifespan in the citrate group was significantly longer than in the heparin group, with a statistically significant difference (WMD = 6.93, 95% CI = 6.30 ~ 7.55, P = .000). Adverse bleeding reactions were significantly less common in the citrate group compared to the heparin group, with a statistically significant difference (RR = 0.14, 95% CI = 0.06 ~ 0.32, P = .000).

Conclusions:

The results of this meta-analysis indicate that citrate anticoagulation is more effective than heparin anticoagulation in continuous renal replacement therapy for patients with acute kidney injury in sepsis. Citrate anticoagulation contributes to improved renal function and extended filter usage and reduces the incidence of adverse bleeding reactions.

• Authors: Sen Lin, MeiYing Xiao, QingZong Cai, YuXia Lin, JinYin Yao, XiaoDong Sun, JinHua Huang
• Journal: Alternative therapies in health and medicine (Altern Ther Health Med) Vol. 29 Issue 8 Pg. 421-425 (Nov 2023) ISSN: 1078-6791 [Print] United States
• PMID: 37652410 (Publication Type: Systematic Review, Meta-Analysis, Journal Article)

Chemical References

• Heparin
• Citric Acid
• Anticoagulants
• Citrates

Topics

• Humans
• Heparin (adverse effects)
• Citric Acid (adverse effects)
• Continuous Renal Replacement Therapy
• Anticoagulants (adverse effects)
• Citrates
• Acute Kidney Injury (drug therapy)
• Sepsis (drug therapy)